Submitted by Anonymous (not verified) on 15 January 2026 - 8:41
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 25, Status: Authorised